Aug 05, 2021 / 03:00PM GMT
Operator
Greetings, and welcome to the Amedisys Q2 2021 Earnings Conference Call. (Operator Instructions) As a reminder, this conference is being recorded.
It is now my pleasure to introduce your host, Nick Muscato. Thank you, Nick. You may begin.
Nick Muscato - Amedisys, Inc. - SVP of Finance
Thank you, operator, and welcome to the Amedisys investor conference call to discuss the results of the second quarter ended June 30, 2021. A copy of our press release, supplemental slides and related Form 8-K filing with the SEC are available on our investor relations page on our website.
Speaking on today's call from Amedisys will be Paul Kusserow, Chairman and Chief Executive Officer; Chris Gerard, President and Chief Operating Officer; and Scott Ginn, Executive Vice President and Chief Financial Officer. Also joining us is Dave Kemmerly, Chief Legal and Government Affairs Officer.
Before we get started with our call, I would like to remind everyone that statements made on this conference call today may constitute forward-looking statements and are
Q2 2021 Amedisys Inc Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot